These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 35530141)

  • 1. Ruscogenin alleviates LPS-triggered pulmonary endothelial barrier dysfunction through targeting NMMHC IIA to modulate TLR4 signaling.
    Wu Y; Yu X; Wang Y; Huang Y; Tang J; Gong S; Jiang S; Xia Y; Li F; Yu B; Zhang Y; Kou J
    Acta Pharm Sin B; 2022 Mar; 12(3):1198-1212. PubMed ID: 35530141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ruscogenin alleviates LPS-induced pulmonary endothelial cell apoptosis by suppressing TLR4 signaling.
    Wu Y; Wang Y; Gong S; Tang J; Zhang J; Li F; Yu B; Zhang Y; Kou J
    Biomed Pharmacother; 2020 May; 125():109868. PubMed ID: 32036210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The myosin II inhibitor, blebbistatin, ameliorates pulmonary endothelial barrier dysfunction in acute lung injury induced by LPS via NMMHC IIA/Wnt5a/β-catenin pathway.
    Zhang J; Pan Z; Zhou J; Zhang L; Tang J; Gong S; Li F; Yu B; Zhang Y; Kou J
    Toxicol Appl Pharmacol; 2022 Sep; 450():116132. PubMed ID: 35716767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ruscogenin attenuates sepsis-induced acute lung injury and pulmonary endothelial barrier dysfunction via TLR4/Src/p120-catenin/VE-cadherin signalling pathway.
    Wang Y; Xue L; Wu Y; Zhang J; Dai Y; Li F; Kou J; Zhang Y
    J Pharm Pharmacol; 2021 Jun; 73(7):893-900. PubMed ID: 33769524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ruscogenin attenuates particulate matter-induced acute lung injury in mice via protecting pulmonary endothelial barrier and inhibiting TLR4 signaling pathway.
    Wang YW; Wu YH; Zhang JZ; Tang JH; Fan RP; Li F; Yu BY; Kou JP; Zhang YY
    Acta Pharmacol Sin; 2021 May; 42(5):726-734. PubMed ID: 32855531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelial Conditional Knockdown of NMMHC IIA (Nonmuscle Myosin Heavy Chain IIA) Attenuates Blood-Brain Barrier Damage During Ischemia-Reperfusion Injury.
    Gong S; Cao G; Li F; Chen Z; Pan X; Ma H; Zhang Y; Yu B; Kou J
    Stroke; 2021 Mar; 52(3):1053-1064. PubMed ID: 33588591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erratum: Author correction to 'Ruscogenin alleviates LPS-triggered pulmonary endothelial barrier dysfunction through targeting NMMHC IIA to modulate TLR4 signaling' [Acta Pharmaceutica Sinica B 12 (2022) 1198-1212].
    Wu Y; Yu X; Wang Y; Huang Y; Tang J; Gong S; Jiang S; Xia Y; Li F; Yu B; Zhang Y; Kou J
    Acta Pharm Sin B; 2022 Jul; 12(7):3198-3199. PubMed ID: 35865100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myosin IIA Regulated Tight Junction in Oxygen Glucose-Deprived Brain Endothelial Cells Via Activation of TLR4/PI3K/Akt/JNK1/2/14-3-3ε/NF-κB/MMP9 Signal Transduction Pathway.
    Lv Y; Liu W; Ruan Z; Xu Z; Fu L
    Cell Mol Neurobiol; 2019 Mar; 39(2):301-319. PubMed ID: 30666520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ruscogenin Alleviates Myocardial Ischemia via Myosin IIA-Dependent Mitochondrial Fusion and Fission Balance.
    Liu JC; Zhao QF; Zhang L; Yu BY; Li F; Kou JP
    Am J Chin Med; 2023; 51(7):1879-1904. PubMed ID: 37650421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The saponin D39 blocks dissociation of non-muscular myosin heavy chain IIA from TNF receptor 2, suppressing tissue factor expression and venous thrombosis.
    Zhai KF; Zheng JR; Tang YM; Li F; Lv YN; Zhang YY; Gao Z; Qi J; Yu BY; Kou JP
    Br J Pharmacol; 2017 Sep; 174(17):2818-2831. PubMed ID: 28547925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NMMHC IIA triggered lipid metabolize reprogramming resulting in vascular endothelial cellular tight junction injury.
    Lv Y; Hong D; Fu L; Qian Y
    Mol Biol Rep; 2022 Apr; 49(4):2805-2819. PubMed ID: 35064404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ruscogenin ameliorates dasatinib-induced intestinal barrier dysfunction via ErbB4/YAP and ROCK/MLC pathways.
    Huang J; Zhou J; Dai Y; Liu Y; Li F; Gong S; Zhang Y; Kou J
    J Nat Med; 2023 Sep; 77(4):735-747. PubMed ID: 37347409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ruscogenin Attenuates Ulcerative Colitis in Mice by Inhibiting Caspase-1-Dependent Pyroptosis via the TLR4/NF-κB Signaling Pathway.
    Li J; Wu H; Zhou J; Jiang R; Zhuo Z; Yang Q; Chen H; Sha W
    Biomedicines; 2024 Apr; 12(5):. PubMed ID: 38790951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. YiQiFuMai lyophilized injection attenuates cerebral ischemic injury with inhibition of neuronal autophagy through intervention in the NMMHC IIA-actin-ATG9A interaction.
    Su L; Liu Y; Ma H; Zheng F; Daia Y; Wang T; Wang G; Li F; Zhang Y; Yu B; Gong S; Kou J
    Phytomedicine; 2022 Jan; 95():153882. PubMed ID: 34968897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonmuscle myosin heavy chain IIA is a critical factor contributing to the efficiency of early infection of severe fever with thrombocytopenia syndrome virus.
    Sun Y; Qi Y; Liu C; Gao W; Chen P; Fu L; Peng B; Wang H; Jing Z; Zhong G; Li W
    J Virol; 2014 Jan; 88(1):237-48. PubMed ID: 24155382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SU5416 attenuated lipopolysaccharide-induced acute lung injury in mice by modulating properties of vascular endothelial cells.
    Huang X; Zhu J; Jiang Y; Xu C; Lv Q; Yu D; Shi K; Ruan Z; Wang Y
    Drug Des Devel Ther; 2019; 13():1763-1772. PubMed ID: 31213766
    [No Abstract]   [Full Text] [Related]  

  • 17. NMMHC IIA Inhibition Ameliorates Cerebral Ischemic/Reperfusion-Induced Neuronal Apoptosis Through Caspase-3/ROCK1/MLC Pathway.
    Wang GY; Wang TZ; Zhang YY; Li F; Yu BY; Kou JP
    Drug Des Devel Ther; 2020; 14():13-25. PubMed ID: 32021088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NMMHC IIA triggers neuronal autophagic cell death by promoting F-actin-dependent ATG9A trafficking in cerebral ischemia/reperfusion.
    Wang G; Wang T; Hu Y; Wang J; Wang Y; Zhang Y; Li F; Liu W; Sun Y; Yu B; Kou J
    Cell Death Dis; 2020 Jun; 11(6):428. PubMed ID: 32513915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The potential mechanism for Hydroxysafflor yellow A attenuating blood-brain barrier dysfunction via tight junction signaling pathways excavated by an integrated serial affinity chromatography and shotgun proteomics analysis approach.
    Lv Y; Fu L
    Neurochem Int; 2018 Jan; 112():38-48. PubMed ID: 29107696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unfractionated heparin attenuates endothelial barrier dysfunction via the phosphatidylinositol-3 kinase/serine/threonine kinase/nuclear factor kappa-B pathway.
    Mu ST; Tang J; Ma JQ; Zhong Y; Liu HZ; Ma XC; Zheng Z
    Chin Med J (Engl); 2020 Aug; 133(15):1815-1823. PubMed ID: 32649510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.